title: Antimetabolites.
authors.affiliation: NCI-Navy Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
authors.forename: E
authors.initials: E
authors.lastname: Chu
authors.forename: P G
authors.initials: PG
authors.lastname: Johnston
authors.forename: C H
authors.initials: CH
authors.lastname: Takimoto
authors.forename: P M
authors.initials: PM
authors.lastname: Politi
authors.forename: J L
authors.initials: JL
authors.lastname: Grem
authors.forename: B A
authors.initials: BA
authors.lastname: Chabner
authors.forename: C J
authors.initials: CJ
authors.lastname: Allegra
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology; D015195:Drug Design; D004351:Drug Resistance / Q000502:physiology; D005467:Floxuridine / Q000494:pharmacology; D005472:Fluorouracil / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology
chemical_list: D000964:Antimetabolites, Antineoplastic; D011687:Purines; D005467:Floxuridine; D003561:Cytarabine; D005472:Fluorouracil; D008727:Methotrexate